Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
NCT01885299 · View on ClinicalTrials.gov ↗
Study Summary
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)
Conditions Studied
Interventions
- RADIATION SRS/SBRT
Study Locations (13)
New Jersey
- AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute — Egg Harbor
- Riverview Medical Center — Red Bank
- NJ Cyberknife at Community Medical Center — Toms River
Pennsylvania
- Geisinger Health System — Danville
- Philadelphia CyberKnife — Philadelphia
- Pottstown Memorial Medical Center — Pottstown
Colorado
- Penrose Cancer Center — Colorado Springs
Florida
- Sylvester Comprehensive Cancer Center, University of Miami — Miami
Georgia
- Southeast Georgia Health System — Brunswick
Michigan
- Henry Ford Health System — Detroit
New York
- Montefiore Medical Center — The Bronx
Tennessee
- Cyberknife at Erlanger — Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2012-03 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01885299
The ClinicalTrials.gov registry entry for NCT01885299 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Radiosurgery Society, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Neoplasms appearing as the primary indexed condition, and to 1 intervention — of which SRS/SBRT is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT01885299 reports 13 study locations spanning 9 distinct geographic areas — top geographies include New Jersey, Pennsylvania, Colorado. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT01885299 about?
NCT01885299 is a clinical study titled "RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT". The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with...
What is the current status of trial NCT01885299?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2012-03. Estimated completion is 2030-12.
What conditions does trial NCT01885299 study?
This clinical trial studies the following conditions: Neoplasms, Trigeminal Neuralgia, Arteriovenous Malformation of Central Nervous System. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT01885299?
The interventions under investigation include: SRS/SBRT (RADIATION). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT01885299?
This trial is sponsored by The Radiosurgery Society, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT01885299 being conducted?
This trial has 13 study locations across Colorado, Florida, Georgia, Michigan, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.